JADE BIOSCIENCES INC (JBIO) Stock Income Statement
NASDAQ:JBIO - Nasdaq - US0080641071 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 53.06M | 74.30M | 81.41M | 53.24M | 23.02M | |||
| Research and Development | N/A | 53.19M | 64.22M | 38.62M | 14.99M | |||
| Selling, General, and Administrative Expenses | 19.96M | 21.11M | 17.19M | 14.62M | 8.04M | |||
| Operating Income | -53.06M | -74.30M | -81.41M | -53.24M | -23.02M | |||
| Interest Income/Expense | 4.48M | 5.04M | 5.95M | 1.83M | 70.00K | |||
| Other Income/Expense | -18.00K | -19.00K | -1.00K | -80.00K | 0.00 | |||
| Non Recurring Items | N/A | -300.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -48.91M | -69.57M | -75.47M | -51.49M | -22.96M | |||
| Income Tax | N/A | 55.00K | 56.00K | 30.00K | 0.00 | |||
| Net Income | -48.96M | -69.63M | -75.52M | -51.51M | -22.99M | |||
| EBITDA | -52.81M | -74.01M | -81.31M | -53.17M | -23.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -59.52 | -85.27 | -100.39 | -73.67 | -34.82 | |||
| Non GAAP EPS | -59.50 | -85.40 | -100.80 | -73.85 | N/A | |||
| Statistics | ||||||||
All data in USD